Buy or sell Redox stock pre IPO via an EquityZen fund

EquityZen is a marketplace for shares of proven pre IPO tech companies

Redox Stock

Data integrator between hospitals and digital health apps

About Redox Stock

Redox accelerates the development and distribution of healthcare software solutions with a full-service integration platform to securely and efficiently exchange data. Healthcare delivery organizations and technology vendors connect once and authorize the data they send and receive across the most extensive interoperable network in healthcare. Redox exists to make healthcare data useful and every patient experience a little bit better.

Funding History

November 2014$470K
October 2015$3.5M
January 2017$9.0M
April 2017$1.0M
August 2018$3.0M
April 2019$33.0M

Management

Software Developer

Andy Kitson

Co-founder

Niko Skievaski

Director

Liam Donohue

Co-founder

James Lloyd

Marketing and Developer Advocate

George Mclaughlin

Software Developer

Christopher "TC" Tobin-Campbell

Product

Nijay Patel

Director of Implementation

Devin Soelberg

HL7 Whisperer

Nick Hatt

Co-founder

Luke Bonney

Other Companies

EquityZen does not have an affiliation with, formal relationship with, or endorsement from Redox or any companies feature above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Join 150K+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

LogoLogo